Status:
UNKNOWN
Promoting Medication Reimbursement Policy (PAPMed)
Lead Sponsor:
Duke Kunshan University
Collaborating Sponsors:
Duke University
Nantong University
Conditions:
Chronic Illness
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Rationale: Chronic non-communicable diseases (NCDs) have become the leading cause of morbidity and mortality in China. Rural NCDs patients are more likely to suffer from poverty. Nantong city has esta...
Detailed Description
Rationale: Chronic non-communicable diseases (NCDs) have become the leading cause of morbidity and mortality in China. Rural NCDs patients are more likely to suffer from poverty. Nantong city has esta...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- To be eligible to register in the medication reimbursement policy, patients need to be:
- Living in the service areas of the village clinics
- Officially diagnosed with hypertension and/or diabetes in a township level hospital or above
- Registered as a hypertensive and/or diabetic patient in the public health service system
- Exclusion criteria:
- Not part of the New Cooperative Medical Scheme (NCMS) for rural residents
Exclusion
Key Trial Info
Start Date :
January 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2021
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04731194
Start Date
January 30 2021
End Date
October 30 2021
Last Update
July 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nantong University
Nantong, Jiangsu, China, 226019